Cortechs.ai | Paul Mirabella Joins Cortechs.ai’ Board of Directors

Paul Mirabella Joins Cortechs.ai’ Board of Directors

Healthcare industry veteran to advise on business development and product advancement

SAN DIEGO–Cortechs.ai Inc. announced today that healthcare and diagnostic imaging industry veteran Paul Mirabella has joined the company’s board of directors as its newest member. Paul, who has worked as a senior executive in the healthcare industry for over 40 years, will play an active role in advising Cortechs.ai on matters including, but not limited to, business development strategy as well as product development and enhancement.

“Paul brings a wealth of knowledge from his 40+ years of experience in diagnostic imaging roles at GE Healthcare and his continued private equity consulting for healthcare businesses that is invaluable for the company”

Paul is currently president and chief executive officer (CEO) of Paul J. Mirabella Investments and Consulting, LLC, where he oversees consulting and investments in the medical device industry and medical diagnostics. He is actively involved in developing imaging solutions to reduce radiation exposure as well as artificial intelligence applications in a range of healthcare sectors, with a current focus in neurology. Previously, he served as president and CEO of GE Healthcare Global Diagnostic Imaging Business and the Global Services Business. More recently, he was a key investor in and served as chairman and CEO of Naviscan, Inc., developer of a high resolution, organ-specific PET scanner. He also held four of the original patents in computed tomography.

“I am extremely passionate about working with innovative technology companies to try to improve the outcomes and efficiency of the health care system,” said Paul. “I look forward to building upon the Cortechs.ai current momentum to deploy leading-edge technology providing medical professionals with deeper insights into the diagnosis of neurodegenerative diseases and, most importantly, elevates patient care.”

Paul Mirabella holds a bachelor’s of science in aerospace engineering and applied mechanics from the Polytechnic Institute of Brooklyn (now NYU) and a master’s in mechanical engineering from the University of Central Florida. He has been a guest lecturer on leadership at the University of California, San Diego Rady School of Management.

“Paul brings a wealth of knowledge from his 40+ years of experience in diagnostic imaging roles at GE Healthcare and his continued private equity consulting for healthcare businesses that is invaluable for the company,” said Dr. Chris Airriess, CEO of Cortechs.ai. “We are honored to have Paul on our board of directors and strive to tap his expertise in our continued goal of helping physicians to provide better patient care with the aid of advanced diagnostic imaging solutions.”

Cortechs.ai is attending the Radiological Society of North America’s Annual Meeting this week and has several new initiatives planned for 2020 to broaden their portfolio of quantitative imaging solutions. Paul will join Cortechs.ai in South Hall booth #4055 from 10 a.m. on Monday, December 2, 2019.

About Cortechs.ai
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists and clinical researchers worldwide with a convenient and cost-effective means to quantify brain structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development abnormalities. Please visit cortechs.ai for further information and follow us on TwitterLinkedIn and Facebook.

###

More Resources

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

02/19/2026

How Cortechs.ai Protects ePHI: HIPAA‑Aligned Controls—and Beyond

Cortechs.ai’s HIPAA-aligned, defense-in-depth security safeguards ePHI across AI workflows—exceeding baseline compliance standards.

02/11/2026

NeuroQuant Normative Database: Advancing Age‑ and Sex‑Specific Brain Volumetry

Learn how the latest updates to the NeuroQuant normative database white paper strengthen age- and sex-specific brain volumetry and enhance clinical confidence.
Scroll to Top